BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35229978)

  • 21. [Comparison of the efficiency of CHOP-based regimen with or without high dose consolidation treatment combined with hematopoietic stem cell transplantation in 63 lymphoblastic lymphoma patients].
    Qin Y; Shi YK; He XH; Han XH; Zhou SY; Liu P; Yang JL; Yang S; Zhang CG; Dong M; Zhou LQ; Wang JW; Feng FY; Sun Y
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):469-73. PubMed ID: 19950562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective study of Burkitt lymphoma treatment in adolescents and adults in Malawi.
    Painschab MS; Westmoreland KD; Kasonkanji E; Zuze T; Kaimila B; Waswa P; El-Mallawany NK; Tomoka T; Mulenga M; Montgomery ND; Fedoriw Y; Gopal S
    Blood Adv; 2019 Feb; 3(4):612-620. PubMed ID: 30796065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-negative plasmablastic lymphoma: not in the mouth.
    Castillo JJ; Winer ES; Stachurski D; Perez K; Jabbour M; Milani C; Colvin GA; Butera JN
    Clin Lymphoma Myeloma Leuk; 2011 Apr; 11(2):185-9. PubMed ID: 21575922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bortezomib in combination with dose-adjusted EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin) induces long-term survival in patients with plasmablastic lymphoma: a retrospective analysis.
    Dittus C; Grover N; Ellsworth S; Tan X; Park SI
    Leuk Lymphoma; 2018 Sep; 59(9):2121-2127. PubMed ID: 29303024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A Case of Malignancy-induced Lactic Acidosis Having Difficulty with Diagnosis].
    Tamura E; Taniguchi Y; Nishiyama M; Yatabe T; Inoue K; Arakawa Y; Mori M; Ikezoe T; Terada Y; Fujimoto S
    Nihon Naika Gakkai Zasshi; 2016 Jun; 105(6):1041-50. PubMed ID: 30168696
    [No Abstract]   [Full Text] [Related]  

  • 26. Primary breast lymphoma.
    Gholam D; Bibeau F; El Weshi A; Bosq J; Ribrag V
    Leuk Lymphoma; 2003 Jul; 44(7):1173-8. PubMed ID: 12916870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience.
    Savage KJ; Al-Rajhi N; Voss N; Paltiel C; Klasa R; Gascoyne RD; Connors JM
    Ann Oncol; 2006 Jan; 17(1):123-30. PubMed ID: 16236753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Efficacy of surgery and rituximab in primary gastric diffuse large B-cell lymphoma].
    Huang HW; Jiang YB; Fu TW; Xu T; Chen XC; Jin ZM; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2016 Jul; 37(7):602-6. PubMed ID: 27535862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A tip of the iceberg: Disseminated plasmablastic lymphoma, diagnosed from a local oral lesion.
    Ke YL; Hsiao HH; Cho SF; Wu CC
    Kaohsiung J Med Sci; 2021 Apr; 37(4):346-347. PubMed ID: 33340392
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).
    Lenz G; Dreyling M; Hoster E; Wörmann B; Dührsen U; Metzner B; Eimermacher H; Neubauer A; Wandt H; Steinhauer H; Martin S; Heidemann E; Aldaoud A; Parwaresch R; Hasford J; Unterhalt M; Hiddemann W
    J Clin Oncol; 2005 Mar; 23(9):1984-92. PubMed ID: 15668467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A success story: how a single targeted-therapy molecule impacted on treatment and outcome of diffuse large B-cell lymphoma.
    Mian M; Augustin F; Kocher F; Gunsilius E; Willenbacher W; Zabernigg A; Zangerl G; Oexle H; Schreieck S; Schnallinger M; Fiegl M
    Anticancer Res; 2014 May; 34(5):2559-64. PubMed ID: 24778077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bortezomib in combination with infusional dose-adjusted EPOCH for the treatment of plasmablastic lymphoma.
    Castillo JJ; Reagan JL; Sikov WM; Winer ES
    Br J Haematol; 2015 May; 169(3):352-5. PubMed ID: 25612847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Orbital plasmablastic lymphoma--comparison of a newly reported entity with diffuse large B-cell lymphoma of the orbit.
    Morley AM; Verity DH; Meligonis G; Rose GE
    Orbit; 2009; 28(6):425-9. PubMed ID: 19929677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A clinicopathological retrospective study of 131 patients with primary bone lymphoma: a population-based study of successively treated cohorts from the British Columbia Cancer Agency.
    Ramadan KM; Shenkier T; Sehn LH; Gascoyne RD; Connors JM
    Ann Oncol; 2007 Jan; 18(1):129-135. PubMed ID: 17018705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic variables and 4-year survival outcomes in CD20 Positive AIDS-Related Lymphoma in the Anti-retroviral treatment era: A Retrospective Review from a Single Centre in KwaZulu-Natal, South Africa.
    Rapiti N; Abdelatif N; Moosa MS
    PLoS One; 2022; 17(9):e0272282. PubMed ID: 36048870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unusual presentation of gastric plasmablastic lymphoma in HIV-negative patient.
    Mihaljevic BS; Todorovic MR; Andjelic BM; Antic DA; Perunicic Jovanovic MD
    Med Oncol; 2012 Jun; 29(2):1186-9. PubMed ID: 21476144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testicular Plasmablastic Lymphoma in an HIV-Negative Patient: A Rare Case Presentation.
    Nwanwene K; Khan NAJ; Alsharedi M
    J Investig Med High Impact Case Rep; 2021; 9():23247096211017423. PubMed ID: 34032157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of optimal treatment on elderly patients with aggressive non-Hodgkin's lymphoma: more patients treated with unaffected response rates.
    Peters FP; Fickers MM; Erdkamp FL; Wals J; Wils JA; Schouten HC
    Ann Hematol; 2001 Jul; 80(7):406-10. PubMed ID: 11529466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Primary breast lymphoma--a report of 27 cases with literature review].
    Cao YB; Wang SS; Huang HQ; Xu GC; He YJ; Guan ZZ; Lin TY
    Ai Zheng; 2007 Jan; 26(1):84-9. PubMed ID: 17222374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stage I-IIE primary non-Hodgkin's lymphoma of the testis: results of a prospective trial by the GOELAMS Study Group.
    Linassier C; Desablens B; Lefrancq T; Le Prise PY; Harousseau JL; Jacob C; Gandhour C; Haillot O; Lucas V; Leloup R; Escoffre M; Colombat P; Tabuteau S;
    Clin Lymphoma; 2002 Dec; 3(3):167-72. PubMed ID: 12521394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.